Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: exertional chest pain major surgical or invasive procedure: cabg x 5 (lima->lad, svg->om with y graft to diag, svg->plv with y graft to rca) history of present illness: 56 yo m with exertional chest pain, abnormal stress test and chest cta that showed lad calcification, referred for cath which showed three vessel disease. past medical history: dm bph gerd htn obesity sleep apnea, uses cpap at night s/p t&a social history: works as technician lives with wife family history: father with first mi at age 55 brother with cabg at age 51 physical exam: admission pe unremarkable. pertinent results: 07:55pm blood wbc-11.7* rbc-2.93* hgb-9.3* hct-25.7* mcv-88 mch-31.7 mchc-36.1* rdw-13.9 plt ct-205 07:55pm blood plt ct-205 03:38am blood pt-13.2* ptt-27.5 inr(pt)-1.2* 07:55pm blood glucose-122* urean-29* creat-1.1 na-135 k-4.5 cl-101 hco3-27 angap-12 10:45am blood wbc-8.7 rbc-2.95* hgb-9.4* hct-26.0* mcv-88 mch-31.9 mchc-36.1* rdw-14.1 plt ct-199 10:45am blood plt ct-199 10:45am blood glucose-132* urean-27* creat-1.2 na-137 k-4.5 cl-102 hco3-27 angap-13 cardiology report echo study date of patient/test information: indication: left ventricular function. intra-op tee for cabg status: inpatient date/time: at 10:13 test: tee (complete) doppler: full doppler and color doppler contrast: none tape number: 2007aw02-: test location: anesthesia west or cardiac technical quality: adequate referring doctor: dr. r. measurements: left ventricle - septal wall thickness: 1.1 cm (nl 0.6 - 1.1 cm) left ventricle - inferolateral thickness: 1.1 cm (nl 0.6 - 1.1 cm) left ventricle - diastolic dimension: 5.2 cm (nl <= 5.6 cm) left ventricle - systolic dimension: 4.4 cm left ventricle - fractional shortening: *0.15 (nl >= 0.29) left ventricle - ejection fraction: >= 55% (nl >=55%) aorta - valve level: 3.3 cm (nl <= 3.6 cm) aorta - ascending: *3.9 cm (nl <= 3.4 cm) aorta - arch: 2.3 cm (nl <= 3.0 cm) aorta - descending thoracic: 2.3 cm (nl <= 2.5 cm) aortic valve - peak velocity: 1.6 m/sec (nl <= 2.0 m/sec) aortic valve - peak gradient: 10 mm hg aortic valve - mean gradient: 5 mm hg aortic valve - lvot peak vel: 0.80 m/sec aortic valve - lvot diam: 2.2 cm aortic valve - valve area: *2.0 cm2 (nl >= 3.0 cm2) interpretation: findings: left atrium: normal la size. right atrium/interatrial septum: normal ra size. normal interatrial septum. no asd by 2d or color doppler. left ventricle: overall normal lvef (>55%). right ventricle: normal rv chamber size and free wall motion. aorta: normal aortic diameter at the sinus level. focal calcifications in aortic root. mildly dilated ascending aorta. focal calcifications in ascending aorta. normal aortic arch diameter. simple atheroma in aortic arch. normal descending aorta diameter. simple atheroma in descending aorta. aortic valve: bicuspid aortic valve. mildly thickened aortic valve leaflets. no as. mild to moderate (+) ar. eccentric ar jet directed toward the anterior mitral leaflet. mitral valve: no ms. physiologic mr (within normal limits). tricuspid valve: mild tr. pulmonic valve/pulmonary artery: physiologic (normal) pr. general comments: a tee was performed in the location listed above. i certify i was present in compliance with hcfa regulations. no tee related complications. the patient was under general anesthesia throughout the procedure. the patient appears to be in sinus rhythm. results were personally post-bypass data conclusions: pre-bypass: 1. the left atrium is normal in size. no atrial septal defect is seen by 2d or color doppler. 2. overall left ventricular systolic function is normal (lvef>55%). 3. right ventricular chamber size and free wall motion are normal. 4. the ascending aorta is mildly dilated. there are simple atheroma in the aortic arch. there are simple atheroma in the descending thoracic aorta. 5. the aortic valve is bicuspid. the aortic valve leaflets are mildly thickened. there is no aortic valve stenosis. by planimetry the is around 2.6 cm2; and continuity 2.0 cm2. mild to moderate (+) aortic regurgitation is seen. the aortic regurgitation jet is eccentric, directed toward the anterior mitral leaflet. 6. physiologic mitral regurgitation is seen (within normal limits). 7. abnormal coronary take off from the aortic root is noted. post-bypass: pt is being paced and is on an infusion of phenylephrine 1. biventriculat systolic function is preserved 2. aorta is intact post decannulation 3. other findings are unchanged electronically signed by , md on 14:23. physician: () brief hospital course: he was taken to the operating room on where he underwent a cabg x 5. he was transferred to the sicu in critical but stbale condition. he was extubated later that same day. his neosynephrine was weaned to off on pod #1. he complained of back pain for which he underwent a cta which showed no dissection. his chest tubes and wires were pulled and he was transferred to the floor on pod #3. beta blockade was titrated and gentle diuresis continued. he made good progress and was cleared for discharge to home with services on pod #5. pt. to make all follow-up appts. as per discharge instructions. medications on admission: doxazosin 2 mg qd discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*90 tablet, delayed release (e.c.)(s)* refills:*2* 4. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po every 6-8 hours as needed for pain. disp:*50 tablet(s)* refills:*0* 5. doxazosin 1 mg tablet sig: two (2) tablet po hs (at bedtime). disp:*60 tablet(s)* refills:*2* 6. ferrous gluconate 300 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 7. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 8. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). disp:*90 tablet(s)* refills:*0* 9. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day) for 7 days: take for 7 days the stop. please take with kcl. disp:*14 tablet(s)* refills:*0* 10. potassium chloride 20 meq packet sig: one (1) po q12h (every 12 hours) for 7 days: take for 7 days then stop. please take with lasix. disp:*14 packets* refills:*0* 11. metoprolol tartrate 50 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*2* discharge disposition: home with service facility: porthsmouth// hh & hospice discharge diagnosis: cad dm bph gerd htn obesity sleep apnea, uses cpap at night s/p t&a discharge condition: good. discharge instructions: call with fever, redness or drainage from incision or weight gain more than 2 pounds in one day or five in one week. shower, no baths, no lotions, creams or powders to incisions. no heavy l;ifting or driving until follow up with surgeon. followup instructions: dr. 4 weeks dr. 2 weeks procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of four or more coronary arteries diagnoses: coronary atherosclerosis of native coronary artery esophageal reflux unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortic valve disorders other and unspecified angina pectoris congenital insufficiency of aortic valve 

Answer: The patient is high likely exposed to